Does Dr. TROY MAJOR have financial conflicts of interest?

Dr. TROY MAJOR (D.O.) has received a total of $417 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $417 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TROY MAJOR?

According to CMS Open Payments data, Dr. TROY MAJOR received funding from INTERSECT ENT ($192), REGENERON HEALTHCARE SOLUTIONS ($115), and INTEGRA LIFESCIENCES CORPORATION ($59).

Does Dr. TROY MAJOR receive research grants or speaking fees?

Dr. TROY MAJOR has received $417 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. TROY MAJOR

D.O.Real-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: OKLAHOMA CITY, OK 73102

NPI Number: 1427003854

LIFETIME INDUSTRY VALUE

$417

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. MAJOR is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in OKLAHOMA CITY, OK.

Between 2021 and 2024, Dr. MAJOR had an overall industry promotional and research financial footprint of $417 as recorded in the federal CMS Open Payments database.

$417 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. MAJOR's primary funding source is INTERSECT ENT, which accounts for $192 (representing 46.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

INTERSECT ENT

Rank 1

$192

46.1%

REGENERON HEALTHCARE SOLUTIONS

Rank 2

$115

27.6%

INTEGRA LIFESCIENCES CORPORATION

Rank 3

$59

14.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.